ReviewJournal of medical case reports2025
Prepubertal testicular neuroendocrine tumor in postpubertal males: a case report and review of the literature.
Review in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn 2016, the World Health Organization classification system of testicular tumors included the new entity prepubertal-type testicular neuroendocrine tumor based on its morphological and molecular profile, and the realization that these tumors may occur in postpubertal men. For treatment and prognostic purposes, it is important to distinguish prepubertal-type testicular neuroendocrine tumor from the usual postpubertal-type testicular neuroendocrine tumor, because the former is benign unlike the latter. The distinction may be challenging. Therefore, we hope that ultrasound examination can play an important role in the differential diagnosis of testicular tumors. CASE PRESENTATIONS: These two cases involved postpubertal males, one is 41-years-old and the other is 62-years-old, they both are Chinese and of the Han ethnicity. Both ultimately underwent surgical treatment without subsequent chemotherapy or other interventions. Up to now, during follow-up, the patients have exhibited no other symptoms.
conclusionPrepubertal-type testicular neuroendocrine tumor is a rare neuroendocrine tumor, and accounts for about 0.23% of testicular tumors. Clinical manifestations and images of it are not specific, routine ultrasound has significant advantages for early detection of lesions and short-term follow-up, and when combined with relevant laboratory tests, it may aid in the diagnosis of the disease, and the treatment is mainly radical surgery, and the prognosis is good.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.